← Open Payments lookup

MARIKA SIMMONS: Open Payments

NPI 1154959526 · BYRAM, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$562 in 28 payments from 10 companies in 2025. Trend: 2023 $331 · 2024 $238 · 2025 $562

Food & beverage: $562
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$197
Astellas Pharma US Inc4$102
ABBVIE INC.5$83
Lundbeck LLC2$40
Otsuka America Pharmaceutical, Inc.2$32
ABIOMED1$31
Lilly USA, LLC2$29
Phathom Pharmaceuticals, Inc.1$20
Novo Nordisk Inc1$14
Sumitomo Pharma America, Inc.1$14

Products named: BREZTRI, Veozah, VRAYLAR, REXULTI, MOUNJARO, UBRELVY, VYEPTI, VOQUEZNA.

Industry payments across MS — which companies pay providers there.